Skip to main content
. 2012 May;166(1):151–167. doi: 10.1111/j.1476-5381.2011.01717.x

Table 1.

Agonist potencies (pEC50 values) for cAMP production at rCT(a), rAMY1(a) and rAMY3(a) receptors

Agonist rCT(a) receptor rAMY1(a) receptor rAMY3(a) receptor
rAmy 8.11 ± 0.12 (15) 9.74 ± 0.10 (23)*** 9.97 ± 0.11 (18)***
rCT 9.28 ± 0.20 (11) 8.90 ± 0.37 (6) 8.30 ± 0.40 (4)*
rαCGRP 7.87 ± 0.28 (7) 9.66 ± 0.13 (13)*** 9.68 ± 0.08 (6)***
rβCGRP 7.54 ± 0.25 (7) 8.87 ± 0.27 (9)* 8.95 ± 0.20 (6)
(Cys(ACM)2,7)hαCGRP <6 (4) <6 (4) <6 (4)
(Cys(Et)2,7)hαCGRP <6 (4) <6 (4) 7.70 ± 0.39 (4)a
rAM 6.82 ± 0.39 (6) 7.12 ± 0.26 (4) 8.04 ± 0.17 (5)*,+
rAM2 6.97 ± 0.30 (6) 7.92 ± 0.27 (4) 8.68 ± 0.09 (5)***

Data are mean ± SEM. Values in parentheses represent the number of individual experiments analysed.

a

Weak partial agonist. Comparisons between receptors were performed by one-way anova followed by Tukey's test (vs. rCT(a),

*

P < 0.05;

**

P < 0.01;

***

P < 0.001. vs. rAMY1(a),

+

P < 0.05). Comparisons of agonists within each column can be found in Figure 3 and Tables S1–S3.

HHS Vulnerability Disclosure